BUZZ-Regeneron shares rise as its quarterly results beat expectations

October 30 - ** Shares of pharmaceutical company Regeneron Pharmaceuticals (REGN.O) rose 3.81% in premarket trading to $850

** The company reported adjusted earnings per share for the third quarter of $20.07, above analysts’ estimate of $16.24 per share — LSEG

** The company reported third-quarter revenue of $5.12 billion, exceeding analysts’ estimate of $4.54 billion — LSEG

** As of the previous trading day’s close, the stock was up about 26% year to date

(To assist non-native English speakers, Reuters has automatically translated its reports into several other languages. Since automated translation may contain errors or lack necessary context, Reuters does not guarantee the accuracy of these automated translations and provides them solely for readers’ convenience. Reuters accepts no responsibility for any harm or loss arising from the use of the automated translation feature.)